<DOC>
	<DOCNO>NCT02961413</DOCNO>
	<brief_summary>This multi-center , prospective , non-interventional cohort study . Its primary objective : 1. ass DILI patient ' clinical characteristic , disease progression influence factor clinical practice ; 2. learn suspect drug cause DILI , rechallenging , liver biochemical abnormality mode , etc .</brief_summary>
	<brief_title>A Prospective Cohort Study Drug-induced Liver Injury China（DILI-P）</brief_title>
	<detailed_description>The main purpose study understand patient DILI clinical outcome influence factor China 's second tertiary general hospital ( include Western medicine hospital , Chinese medicine hospital andIntegrated traditional Chinese Western Medicine Hospital ) vulnerabilities drug-induced liver injury specialist hospital ( tuberculosis hospital , Pulmonary , etc . ) mainland . The main purpose 1. ass DILI patient ' clinical outcome influence factor real world ; 2. learn suspect drug cause DILI , rechallenging , liver biochemical abnormality mode , etc . Secondary objective 1. ass compliance DILI practice 2015 vision DILI guideline china . ; 2. evaluate histological feature DILI patient ; 3. assessment DILI characteristic , prognosis influencing factor specific population ( elderly , child underlie liver disease background , etc . )</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<criteria>Diagnosis DILI patient various type severity accord 2015 version Chinese DILI treatment guideline RUCAM ≥6 , RUCAM 35 require three expert determine druginduced liver injury patient provide inform consent form nondruginduced liver injury</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>